Corporate

Mylan CEO defends EpiPen strategy, questions pricing model in the U.S.

Mylan CEO defends EpiPen strategy, questions pricing model in the U.S.

By

Heather Bresch's appearance at industry summit came after she declined to attend a congressional hearing scheduled for the same day.

Five things for pharma marketers to know: Thursday, December 1, 2016

Five things for pharma marketers to know: Thursday, December 1, 2016

By

Valeant doesn't plan to offload Salix; heart docs back Califf as commish; Saunders says pricing issues aren't affected by election

Five things for pharma marketers to know: Wednesday, November 23, 2016

Five things for pharma marketers to know: Wednesday, November 23, 2016

By

Lilly's experimental Alzheimer's drug fails in another trial; two more patients die during trial for Juno's CAR-T therapy; NEJM launches platform in China

Walgreens.com to publish patient reviews of drug effectiveness

Walgreens.com to publish patient reviews of drug effectiveness

By

The drugstore chain added drug effectiveness reviews and other information from PatientsLikeMe to its website.

Five things for pharma marketers to know: Thursday, November 10, 2016

Five things for pharma marketers to know: Thursday, November 10, 2016

By

Mylan reports third-quarter loss; analysts say drug-pricing restrictions less likely under Trump; the FDA limits citizen petitions

Astellas boosts pharma's rep with corporate branding push

Astellas boosts pharma's rep with corporate branding push

By

The new TV spot was developed with CNN and Edelman.

Best Corporate Branding Campaign of 2016

Best Corporate Branding Campaign of 2016

By

Listen Up was the internal communications element Level Brand created to help employees learn how to improve member experience.

Best Agency Self-Promotion of 2016

Best Agency Self-Promotion of 2016

By

Klick Ideas Exchange united leading CEOs and high-level executives of biotech and pharmaceutical companies, thought leaders, and other industry influencers to explore issues that are shaping the future of healthcare.

Five things for pharma marketers to know: Monday, September 26, 2016

Five things for pharma marketers to know: Monday, September 26, 2016

By

Pfizer drops plans to split into two companies; Merck's Keytruda gains competitive edge in China; Apple may be developing health software

McCann Health forms new global consultancy

McCann Health forms new global consultancy

By

The consultancy includes Double Helix, which was acquired by McCann in 2012.

Five things for pharma marketers to know: Wednesday, September 21, 2016

Five things for pharma marketers to know: Wednesday, September 21, 2016

By

Drugmakers to remove incentives for sales reps marketing antibiotics; Mylan CEO defends EpiPen pricing; fitness trackers don't help people lose weight

Five things for pharma marketers to know: Tuesday, September 20, 2016

Five things for pharma marketers to know: Tuesday, September 20, 2016

By

GSK names new CEO; the FDA approves first Duchenne muscular dystrophy drug; Sanofi files Lantus patent lawsuit against Merck

Five things for pharma marketers to know: Wednesday, August 24, 2016

Five things for pharma marketers to know: Wednesday, August 24, 2016

By

Retzlaff files a complaint against Turing; Pfizer to buy antibiotics from AstraZeneca; Mylan's marketing for EpiPen faces criticism

In Medivation deal, Pfizer will gain an oncology blockbuster

In Medivation deal, Pfizer will gain an oncology blockbuster

By

Pfizer's commercial expertise in urology and oncology could help propel Medivation's Xtandi to new heights.

Five things for pharma marketers to know: Monday, August 22, 2016

Five things for pharma marketers to know: Monday, August 22, 2016

By

Pfizer to acquire cancer drugmaker Medivation; Valeant names new CFO; Apple acquires health data startup

Reimbursement rather than Brexit more likely to impact how drugmakers order global launches

Reimbursement rather than Brexit more likely to impact how drugmakers order global launches

By

The current reimbursement climate is more likely to impact how drugmakers order their global product launches than the U.K.'s vote to exit the E.U.

Bolstered by new data, Radius Health focuses on unmet needs in the osteoporosis market

Bolstered by new data, Radius Health focuses on unmet needs in the osteoporosis market

By

Only one new osteoporosis drug has been approved over the last six years.

Lobbyists create off-label principles following FDA lawsuits

By

PhRMA and BIO, which represent life sciences firms, developed principles about sharing truthful and non-misleading information with payers and providers.

Five things for pharma marketers to know: Monday, August 8, 2016

Five things for pharma marketers to know: Monday, August 8, 2016

By

Valeant reorganizes executive team; experimental asthma drug developed by Novartis shows promising results; Teva launches generic Gleevec

Event company acquires AstraZeneca's medical meetings app

Event company acquires AstraZeneca's medical meetings app

By

The event technology platform plans to integrate a conference note-taking app developed by AstraZeneca and DigitasLBi.

Five things for pharma marketers to know: Wednesday, August 3, 2016

Five things for pharma marketers to know: Wednesday, August 3, 2016

By

Merck and Allergan reportedly vying to buy Biogen; drugmakers fight California measure capping drug prices; few seniors use the web to look for health info

Christine Coyne on the moment with a male boss that influenced her career

Christine Coyne on the moment with a male boss that influenced her career

By

A story about a boss giving away a woman's bonus to a man based on his breadwinning status resonated with Hall of Femme attendees.

Five things for pharma marketers to know: Thursday, July 28, 2016

Five things for pharma marketers to know: Thursday, July 28, 2016

By

Vertex says Orkambi is on the blockbuster track; Advent and CVC reportedly made offers to buy inVentiv Health; the FDA approves Sanofi's Adlyxin

Five things for pharma marketers to know: Wednesday, July 13, 2016

Five things for pharma marketers to know: Wednesday, July 13, 2016

By

Gilead reportedly avoiding paying billions in taxes; Merck plans to cut R Sage's treatment for postpartum depression meets trial goal

Astellas hires Joseph Devaney as government affairs VP

Astellas hires Joseph Devaney as government affairs VP

By

He is replacing Martin Golden, who was appointed head of global marketing strategy.

Five things for pharma marketers to know: Thursday, June 30, 2016

Five things for pharma marketers to know: Thursday, June 30, 2016

By

BI axes 725 U.S. jobs; Bill Gates supports current U.S. drug pricing; drugmakers are targeting smaller hospitals

Five things for pharma marketers to know: Friday, June 17, 2016

Five things for pharma marketers to know: Friday, June 17, 2016

By

Hillary Clinton receives more donations from pharma than republicans; biotech reps have highest salaries; NICE recommends Yervoy-Opdivo combo

Reputation Institute: Talc lawsuits not hurting J&J's image with millennials

Reputation Institute: Talc lawsuits not hurting J&J's image with millennials

By

According to research conducted in the first quarter, the healthcare products company has a sterling image with millennials despite a series of legal judgments against the company.

What millennial women expect in the workplace

What millennial women expect in the workplace

By

Three executives shared some of the challenges women face in the workplace and how they want to shape the next generation of female leaders.

Aetna hires new chief comms officer

Aetna hires new chief comms officer

By

Her hire comes as the insurance giant is merging with Humana in a $37 billion deal.

OPINION

Email Newsletters